Generic drugs were introduced decades ago as a free-market alternative to expensive name brands, in contrast to Europe’s government-negotiated system. But although we assume generic versions are identical to their name-brand counterparts, they can differ in important ways. And as the price of generics has spiked, legislators and others are questioning the role of this multibillion-dollar industry in our health care system.

Guests

  • Jeremy Greene MD; Professor of Medicine and the History of Medicine, Johns Hopkins University School of Medicine; Author, “Generic: The Unbranding of Modern Medicine.”

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

The Politics Hour – August 17, 2018

Friday, Aug 17 2018How should the D.C. provide oversight for its public schools? What do new polling numbers and endorsements suggest about the Maryland Gubernatorial race? And how are Virginia's Democrats planning to flip key districts in November?